• Login
    View Item 
    •   Home
    • Hospital Research
    • Leinster
    • St. Vincent's University Hospital
    • View Item
    •   Home
    • Hospital Research
    • Leinster
    • St. Vincent's University Hospital
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Map of Submissions

    Home Page
    UlsterN
    4715
    UlsterS
    4715
    Connacht
    1603
    Munster
    48
    Leinster
    426

    Browse

    All of Lenus, The Irish Health RepositoryCommunitiesTitleAuthorsDate publishedSubjectsThis CollectionTitleAuthorsDate publishedSubjects

    My Account

    LoginRegister

    About

    About LenusDirectory of Open Access JournalsOpen Access Publishing GuideNational Health Library & Knowledge ServiceGuide to Publishers' PoliciesFAQsTerms and ConditionsVision StatementRIAN Pathways to Irish ResearchHSE position statement on Open AccessNational Open Research Forum (NORF)Zenodo (European Open Research repository)

    Statistics

    Display statistics

    Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Publisher version
    View Source
    Access full-text PDFOpen Access
    View Source
    Check access options
    Check access options
    Authors
    Mak, George J
    Ledwidge, Mark T
    Watson, Chris J
    Phelan, Dermot M
    Dawkins, Ian R
    Murphy, Niamh F
    Patle, Anil K
    Baugh, John A
    McDonald, Kenneth M
    Affiliation
    St. Vincent's University Hospital, Dublin, Ireland.
    Issue Date
    2012-02-01T10:29:29Z
    MeSH
    Aged
    Aged, 80 and over
    Aldosterone Antagonists/*administration & dosage
    Biological Markers/blood
    Collagen Type I/*blood
    Collagen Type III/*blood
    Echocardiography, Doppler
    Female
    Follow-Up Studies
    Heart Failure, Diastolic/*blood/drug therapy/physiopathology
    Heart Ventricles/*physiopathology/ultrasonography
    Humans
    Male
    Procollagen/*blood
    Prospective Studies
    Radioimmunoassay
    Spironolactone/administration & dosage/*analogs & derivatives
    Treatment Outcome
    Show allShow less
    
    Metadata
    Show full item record
    Citation
    J Am Coll Cardiol. 2009 Oct 27;54(18):1674-82.
    Journal
    Journal of the American College of Cardiology
    URI
    http://hdl.handle.net/10147/207496
    DOI
    10.1016/j.jacc.2009.08.021
    PubMed ID
    19850207
    Abstract
    OBJECTIVES: This study was designed to evaluate the impact of eplerenone on collagen turnover in preserved systolic function heart failure (HFPSF). BACKGROUND: Despite growing interest in abnormal collagen metabolism as a feature of HFPSF with diastolic dysfunction, the natural history of markers of collagen turnover and the impact of selective aldosterone antagonism on this natural history remains unknown. METHODS: We evaluated 44 patients with HFPSF, randomly assigned to control (n = 20) or eplerenone 25 mg daily (n = 24) for 6 months, increased to 50 mg daily from 6 to 12 months. Serum markers of collagen turnover and inflammation were analyzed at baseline and at 6 and 12 months and included pro-collagen type-I and -III aminoterminal peptides, matrix metalloproteinase type-2, interleukin-6 and -8, and tumor necrosis factor-alpha. Doppler-echocardiographic assessment of diastolic filling indexes and tissue Doppler analyses were also obtained. RESULTS: The mean age of the patients was 80 +/- 7.8 years; 46% were male; 64% were receiving an angiotensin-converting enzyme inhibitor, 34% an angiotensin-II receptor blocker, and 68% were receiving beta-blocker therapy. Pro-collagen type-III and -I aminoterminal peptides, matrix metalloproteinase type-2, interleukin-6 and -8, and tumor necrosis factor-alpha increased with time in the control group. Eplerenone treatment had no significant impact on any biomarker at 6 months but attenuated the increase in pro-collagen type-III aminoterminal peptide at 12 months (p = 0.006). Eplerenone therapy was associated with modest effects on diastolic function without any impact on clinical variables or brain natriuretic peptide. CONCLUSIONS: This study demonstrates progressive increases in markers of collagen turnover and inflammation in HFPSF with diastolic dysfunction. Despite high background utilization of renin-angiotensin-aldosterone modulators, eplerenone therapy prevents a progressive increase in pro-collagen type-III aminoterminal peptide and may have a role in management of this disease. (The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure; NCT00505336).
    Language
    eng
    ISSN
    1558-3597 (Electronic)
    0735-1097 (Linking)
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.jacc.2009.08.021
    Scopus Count
    Collections
    St. Vincent's University Hospital

    entitlement

    Related articles

    • Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
    • Authors: Udelson JE, Feldman AM, Greenberg B, Pitt B, Mukherjee R, Solomon HA, Konstam MA
    • Issue date: 2010 May
    • Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
    • Authors: Iraqi W, Rossignol P, Angioi M, Fay R, Nuée J, Ketelslegers JM, Vincent J, Pitt B, Zannad F
    • Issue date: 2009 May 12
    • A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
    • Authors: Kosmala W, Przewlocka-Kosmala M, Szczepanik-Osadnik H, Mysiak A, O'Moore-Sullivan T, Marwick TH
    • Issue date: 2011 Dec
    • Eplerenone in systemic right ventricle: double blind randomized clinical trial. The evedes study.
    • Authors: Dos L, Pujadas S, Estruch M, Mas A, Ferreira-González I, Pijuan A, Serra R, Ordóñez-Llanos J, Subirana M, Pons-Lladó G, Marsal JR, García-Dorado D, Casaldàliga J
    • Issue date: 2013 Oct 15
    • Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF).
    • Authors: Deswal A, Richardson P, Bozkurt B, Mann DL
    • Issue date: 2011 Aug
    National Health Library & Knowledge Service | Health Service Executive | Dr Steevens' Hospital | Dublin 8 | Ireland
    lenus@hse.ie | Tel +353 (1) 6352558
    DSpace software copyright © 2002-2017  DuraSpace
    Contact Us | Disclaimer
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.